EISAI CO
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1941-12-06
- Employees
- 11K
- Market Cap
- $12B
- Website
- http://www.eisai.co.jp
A Study of E7080 in Subjects With Solid Tumor
- First Posted Date
- 2010-12-30
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT01268293
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Completed
- Conditions
- Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
- Interventions
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 108
- Registration Number
- NCT01264822
E2022 Patch Formulation Single Dose Phase I Study
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT01253434
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 894
- Registration Number
- NCT01251718
A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01202071
An Study of Efficacy and Safety of Clevudine
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT01192854
- Locations
- 🇨🇳
Xiangya hospital, Changsha, Hunan, China
Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)
Phase 4
Completed
- Conditions
- Peripheral Neuropathy
- Interventions
- First Posted Date
- 2010-08-31
- Last Posted Date
- 2012-11-07
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 1072
- Registration Number
- NCT01192113
- Locations
- 🇨🇳
The 1st Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳The General Hospital of the People's Liberation Army, Beijing, Beijing, China
🇨🇳The institute of rehabilitation medicine, Beijing, China
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2013-04-01
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 1184
- Registration Number
- NCT01190657
- Locations
- 🇨🇳
Chinese People's Liberation Army General Hospital of Beijing Military, Beijing, China
🇨🇳Chongqing First People's Hospital, Chongqing, China
🇨🇳The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2019-03-11
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT01151540
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 10238
- Registration Number
- NCT01129596